Interferon-γ and cancer immunoediting

被引：112

作者：

Dunn, GP ^{[1
]}

Ikeda, H ^{[1
]}

T Bruce, A ^{[1
]}

Koebel, C ^{[1
]}

Uppaluri, R ^{[1
]}

Bui, J ^{[1
]}

Chan, R ^{[1
]}

Diamond, M ^{[1
]}

White, JM ^{[1
]}

Sheehan, KCF ^{[1
]}

Schreiber, RD ^{[1
]}

机构：

[1] Washington Univ, Sch Med, Dept Pathol & Immunol, Ctr Immunol, St Louis, MO 63110 USA

来源：

IMMUNOLOGIC RESEARCH | 2005年 / 32卷 / 1-3期

关键词：

interferon-gamma; cancer; immunosurveillance; signal transduction; cancer immunoediting; lymphocytes;

D O I：

10.1385/IR:32:1-3:231

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Over the last 12 yr, we have shown that interferon-gamma and lymphocytes collaborate to regulate tumor development in mice. Specifically, we found that the immune system not only prevents the growth of primary (carcinogen-induced and spontaneous) and transplanted tumors but also sculpts the immunogenicity of tumors that form. These observations led us to refine the old and controversial "cancer immunosurveillance" hypothesis of Burnet and Thomas into one that we termed cancer immunoediting that better emphasizes the paradoxical host-protective and tumor-sculpting roles of immunity on developing tumors. Our current work focuses on defining the molecular mechanisms that underlie cancer immunoediting and exploring the implications of this process for cancer immunotherapy.

引用

页码：231 / 245

页数：15

共 50 条

[1] Interferon-γ and cancer immunoediting
Gavin P. Dunn
Hiroaki Ikeda
Allen T. Bruce
Catherine Koebel
Ravi Uppaluri
Jack Bui
Ruby Chan
Mark Diamond
J. Michael White
Kathleen C. F. Sheehan
Robert D. Schreiber
Immunologic Research, 2005, 32 : 231 - 245
[2] Type I interferon and cancer immunoediting
Smyth, MJ
NATURE IMMUNOLOGY, 2005, 6 (07) : 646 - 648
[3] Type I interferon and cancer immunoediting
Mark J Smyth
Nature Immunology, 2005, 6 : 646 - 648
[4] Tumour cells can escape antiproliferative pressure by interferon-β through immunoediting of interferon receptor expression
Felix Hiebinger
Aiste Kudulyte
Huanting Chi
Sebastian Burbano De Lara
Doroteja Ilic
Barbara Helm
Hendrik Welsch
Viet Loan Dao Thi
Ursula Klingmüller
Marco Binder
Cancer Cell International, 23
[5] Tumour cells can escape antiproliferative pressure by interferon-β through immunoediting of interferon receptor expression
Hiebinger, Felix
Kudulyte, Aiste
Chi, Huanting
Burbano De Lara, Sebastian
Ilic, Doroteja
Helm, Barbara
Welsch, Hendrik
Dao Thi, Viet Loan
Klingmueller, Ursula
Binder, Marco
CANCER CELL INTERNATIONAL, 2023, 23 (01)
[6] Interferon α in cancer immunoediting: From elimination to escape
Vidal, Paolo
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 91 (05)
[7] Cancer immunotherapy:: The interferon-α experience
Kirkwood, J
SEMINARS IN ONCOLOGY, 2002, 29 (03) : 18 - 26
[8] The Two Faces of Interferon-γ in Cancer
Zaidi, M. Raza
Merlino, Glenn
CLINICAL CANCER RESEARCH, 2011, 17 (19) : 6118 - 6124
[9] Cancer immunoediting
Varanasi, Siva Karthik
Kaech, Susan M.
Bui, Jack D.
CELL, 2022, 185 (21) : 4038 - +
[10] Interferon-β and Interferon-λ Signaling Is Not Affected by Interferon-Induced Refractoriness to Interferon-α In Vivo
Makowska, Zuzanna
Duong, Francois H. T.
Trincucci, Gaia
Tough, David F.
Heim, Markus H.
HEPATOLOGY, 2011, 53 (04) : 1154 - 1163

← 1 2 3 4 5 →